Bulletin
Investor Alert

New York Markets Open in:

Mylan N.V.

NAS: MYL

GO
/marketstate/country/us

After Hours

MYL
/zigman2/quotes/209413137/composite

$

14.62

Change

-0.02 -0.14%

Volume

Volume 467,993

Sep 28, 2020, 7:38 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209413137/composite

Previous close

$ 14.42

$ 14.64

Change

+0.22 +1.53%

Day low

Day high

$14.57

$14.84

Open
Open: 14.64

52 week low

52 week high

$12.75

$23.11

Open

Market cap

$7.45B

Average volume

4.99M

P/E ratio

27.95

Rev. per Employee

$326,506

EPS

0.52

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/myl

MarketWatch News on MYL

  1. How Pfizer Plans to Lead the Industry in Gene Therapies

    10:29 a.m. Sept. 16, 2020

    - Barron's Online

  2. Mylan to buy Aspen Pharmacare's Europe thrombosis business for equivalent of $756.8 mln

    6:17 a.m. Sept. 8, 2020

    - Tomi Kilgore

  3. Mylan expects to close acquisition of Pfizer's Upjohn business in Q4

    6:47 a.m. Aug. 6, 2020

    - Ciara Linnane

  4. Mylan tweaks full-year revenue guidance to $11.5 bln to $12.0 bln

    6:46 a.m. Aug. 6, 2020

    - Ciara Linnane

  5. Mylan Q2 revenue $2.73 bln, down 4%; FactSet consensus $2.74 bln

    6:45 a.m. Aug. 6, 2020

    - Ciara Linnane

  6. Mylan expects overall COVID-19 recovery efforts will be slower than expected

    6:46 a.m. Aug. 6, 2020

    - Ciara Linnane

  7. Mylan Q2 EPS 8 cents vs loss per share 33 cents; FactSet consensus 99 cents

    6:45 a.m. Aug. 6, 2020

    - Ciara Linnane

  8. Pfizer Stock Jumps on Earnings Beat and Vaccine Progress

    11:29 a.m. July 28, 2020

    - Barron's Online

  9. Pfizer Reports Earnings Tomorrow. Here’s What to Expect.

    10:01 a.m. July 27, 2020

    - Barron's Online

  10. Here Are a Few Sectors and Three Dozen Stocks for a Blue Wave

    1:30 p.m. July 7, 2020

    - Barron's Online

  11. Podcast: 355 Retailers File for Bankruptcy

    12:20 p.m. June 24, 2020

    - Barron's Online

  12. 10 of the Cheapest Stocks in the S&P 500

    4:36 p.m. June 24, 2020

    - Barron's Online

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/myl

Other News on MYL

  1. Raymond James Thinks Mylan’s Stock is Going to Recover

    4:35 p.m. Sept. 24, 2020

    - SmarterAnalyst

  2. Pfizer Is Your Best Bet at a Covid-19 Vaccine Play

    12:56 p.m. Sept. 22, 2020

    - InvestorPlace.com

  3. European regulators thumbs up on Mylan-Upjohn tie-up

    7:26 a.m. Sept. 15, 2020

    - Seeking Alpha

  4. Raymond James Maintains Their Buy Rating on Mylan (MYL)

    4:45 p.m. Sept. 8, 2020

    - SmarterAnalyst

  5. Wall Street Analysts Are Bullish on Top Healthcare Picks

    4:45 p.m. Sept. 1, 2020

    - SmarterAnalyst

  6. Mylan and Biocon launch of Semglee in U.S.

    6:55 a.m. Aug. 31, 2020

    - Seeking Alpha

  7. Biogen Stock Is a Big Risk Worth Taking

    9:30 a.m. Aug. 26, 2020

    - Charley Grant

  8. Mylan launches first generic to Tecfidera in multiple sclerosis

    8:46 a.m. Aug. 19, 2020

    - Seeking Alpha

  9. FDA OKs Mylan's generic version of Biogen MS med Tecfidera

    3:36 p.m. Aug. 18, 2020

    - Seeking Alpha

  10. Understanding Mylan's Unusual Options Activity

    10:09 a.m. Aug. 18, 2020

    - benzinga.com

  11. A Director at Mylan (MYL) is Buying Shares

    6:08 a.m. Aug. 14, 2020

    - SmarterAnalyst

  12. Why Pfizer's 4% Yield Is Your Best Covid-19 Vaccine Play

    12:24 p.m. Aug. 13, 2020

    - Seeking Alpha

  13. Mylan: Treating Debt And Intangibles

    12:19 a.m. Aug. 11, 2020

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/myl

Press Releases on MYL

  1. Etomidate Market Global Research and Clinical Survey Report 2020 to 2025

    2:53 a.m. Sept. 23, 2020

    - Market Insight Reports

  2. Orally Disintegrating Tablet (ODT) Market Size, Share and Growth 2020 to 2026

    3:33 a.m. Sept. 15, 2020

    - Market Insight Reports

  3. Immunosuppressants Market To Be Worth US Dollor 45,000 Mn By 2027

    3:24 a.m. Sept. 9, 2020

    - Global QYResearch

  4. Mylan to Acquire Aspen's Thrombosis Business in Europe

    2:00 a.m. Sept. 8, 2020

    - PR Newswire - PRF

  5. S&P 500 Movers: MYL, WMT

    10:20 a.m. Sept. 1, 2020

    - MarketNewsVideo.com

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.